Medical School

Division of Blood and Marrow Transplantation

Department of Pediatrics

Michael Verneris, MD

MEDPEDS2 - Image - 180x222 - Michael Verneris

Academic Title

Associate Professor

Clinical Title

Pediatric Blood and Marrow Transplant Physician


  • Pediatrics
  • Cancer
  • Transplants
  • Pediatric Blood and Marrow Transplant


  • Journey Clinic -- Center for Pediatric Blood and Marrow Transplantation


Medical School
Dartmouth-Brown Program in Medicine
Children's National Medical Center, Washington, DC
Stanford University

Contact Info


(612) 626-2961

(612) 626-3941

Office Address
Pediatric BMT
425 E River Rd
Minneapolis, MN 55455

Mailing Address
Pediatrics BMT
MMC 366 Mayo
8366A (Campus Delivery Code)
420 Delaware St SE
Minneapolis, MN 55455

Bio Statement

Dr. Verneris is an Associate Professor of Pediatrics, Division of Blood and Marrow Transplantation, and the Cancer Center. His clinical interests include hematopoietic cell transplantation for acute leukemias, prevention of graft-versus-host disease and graft-versus-leukemia.

He received his medical degree in 1992 from the Dartmouth-Brown Program in Medicine (Hanover, New Hampshire and Providence, Rhode Island). He completed his Pediatric Internship and Residency at Children's National Medical Center, Washington, D.C. His Pediatric Hematology/Oncology Fellowship was completed at the Lucile Salter Packard Children's Hospital at Stanford University, Palo Alto, California, where he was a staff physician from 1998-2002, prior to joining the faculty at the University of Minnesota. He is board certified in Pediatrics and Pediatric Hematology/Oncology.

Dr. Verneris's research interests include immunology, transplantation biology and therapy, and translational research. Areas of specific interest include NK cell development and activating and inhibitory NK receptors. Current laboratory efforts are focused on understanding the signaling pathways of a number of these receptors and how such pathways are influenced by allogeneic bone marrow transplantation and immunosuppressive medications. Other studies are aimed at enhancing NK cell responses to malignant diseases and adoptive transfer of NK cells to kill residual leukemia/cancer cells.

He serves on the University of Minnesota Institutional Biosafety Committee and the All-University Radiation Protection Advisory Committee. Dr. Verneris is a reviewer for nine scientific journals. He has been the recipient of numerous awards and is currently recipient of the Alexander Charles Jundt Research Award. Dr. Verneris is Principal Investigator on a number of grants, including two from the National Institutes of Health (K08-HL004505 and P30CA077598-07, pilot 19) and the Children's Oncology Group. He has over 90 peer-reviewed publications and has co-authored 6 text book chapters.

Research Interests

  1. Laboratory Based Research:
    • NK cell Development from Progenitor cells
    • Effect of Immune Suppressive Agents on NK cell Function
    • Role of Co-stimulatory Molecules on NK cell Function
  2. Translational Research:
    • Large Scale Expansion of NK cells and Adoptive Transfer following Allogeneic Hematopoietic Cell Transplantation
  3. Clinical Research:
    • Double Umbilical Cord Blood Transplantation for Relapsed and Refractory Acute Leukemias
    • Hematopoietic Cell Transplantation for Pediatric Solid Tumors

  • 1999-2001 Fellow Scholar Award, American Society of Hematology
  • 2000 Honorable Mention, Young Investigator Award, American Society of Pediatric Hematology/Oncology
  • 2003 Charles Jundt Research Award, University of Minnesota
  • 2011 Relentless For A Cure Award, Leukemia and Lymphoma Society, MN Chapter
  • ©2014 Regents of the University of Minnesota. All rights reserved.
  • The University of Minnesota is an equal opportunity educator and employer
  • Last modified on April 24, 2013